Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02576444
Title OLAParib COmbinations (OLAPCO)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Joseph Paul Eder
Indications

Advanced Solid Tumor

Therapies

Adavosertib + Olaparib

Olaparib

Capivasertib + Olaparib

AZD6738 + Olaparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale Cancer Center New Haven Connecticut 06520-8028 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Cleveland Clinic Taussig Cancer Institute Cleveland Ohio 44195 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field